Navigation Links
Halleland Health Consulting Hires New Director of Lifescience Business Development Peter T. Bianco
Date:5/1/2008

Bianco's strategic business experience brings depth to specialized

consulting group

MINNEAPOLIS, May 1 /PRNewswire/ -- Halleland Health Consulting, a wholly owned subsidiary of Minneapolis law firm Halleland Lewis Nilan & Johnson, P.A., announces the hire of Peter T. Bianco as Director of Lifescience Business Development. In addition to coaching bioscience businesses through start-up and growth challenges with the consulting subsidiary, Bianco's work will also be integrated with the law firm's health care and business practice areas.

"Bianco's expertise around medical technologies, services, and infrastructure make him an exceptional addition to our accomplished health consulting team," said Brian Johnson, president of Halleland Lewis Nilan & Johnson. "His strategic and hands-on experience in the bioscience industry brings another level of clarity and competency to our clients."

Bianco comes to the firm after serving as the president of Bioscience Business Development, LLC, where he provided strategic business development for early-stage and large businesses focused on a variety of medical technologies and related services with specific focus on successful early stage lifescience technology commercialization and the financial and physical infrastructure to support it.

Prior to that, he served as the chief executive officer of University Enterprise Laboratories in St. Paul, Minn. His previous experience also includes over ten years in Orthopedic product management, product development engineering and medical device marketing for medical device giant Johnson & Johnson Professional, Inc. and Dow Corning Wright. He began his career in Orthopedic Biomechanics Research at the Mayo Clinic in Rochester, Minn. and Hennepin County Medical Center in Minneapolis, Minn.

He is a founder and board member of Suffolk University's Center for Innovation and Change Leadership (CICL) in Boston, Mass. where he earned his MBA. He received his bachelor's degree in physiology from the University of Minnesota. He serves as vice chairman of the board of directors for the Midwest Orthopedic Research Foundation (MORF) and is a member of the business advisory board for the Regulatory and Clinical Research Institute (RCRI) and Orthopedic Research Society (ORS). Peter currently resides in St. Paul, Minn. with his family.

About Halleland Health Consulting

Halleland Health Consulting, a wholly owned subsidiary of Halleland Lewis Nilan & Johnson, P.A., brings experienced health care professionals with operational, policy and business expertise together with attorneys who specialize in an array of health care and regulatory issues. The integrated team of attorneys, health care providers, public health professionals and health care operations and policy experts helps to guide clients through the maze of legal and business complexities, yielding fresh solutions to contemporary health care problems. Founded in 1996, Halleland Lewis Nilan & Johnson has built its reputation by putting clients first and building a practice centered on values - thus defining the next generation of law firm. In addition to health care, the firm has practice areas in business law and intellectual property litigation, commercial litigation, labor and employment and product liability/mass tort litigation.


'/>"/>
SOURCE Halleland Health Consulting
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Halleland Health Consulting Assists PBMs in Achieving URAC Accreditation for Pharmacy Benefit Management
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... "Today, MHA and mental health advocates ... systems reform legislation in more than fifty years. We applaud the bipartisan action ... elected officials to improving mental health services and supports in our nation. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children ... bodies, a researcher at the Icahn School of Medicine at Mount Sinai has ... found that when young children are exposed to secondhand marijuana smoke, measurable amounts ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the release of Smart Device Remote Control through a new partnership with Splashtop ... platforms and strengthens its mobile solutions to help businesses maximize their uptime and ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Presence Technology, S.L. (“Presence”) for a purchase price of approximately $17.4 million ... considerations. Presence’s annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, ...
(Date:12/7/2016)... ... 07, 2016 , ... It is vital for any lab to secure funding, ... The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to ... to operate in a GLP (Good Laboratory Practice) fashion. , With features designed to ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology: